abstract |
Described is an agent for transdermal application, characterized in that it contains esters of 13-ethyl-17β-hydroxy-11-methylene-18,19-dinor-17α-pregn-4-ene-20-yne-3-one with 1 to 20 carbon atoms in the ester group, optionally in combination with one or two oestrogens. |